Unimolecular Photodynamic Nanoassembly for Amplified Photoimmunotherapy via Expanded ROS Generation and Hypoxia...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Photodynamic therapy (PDT) shows promise for noninvasive cancer treatment by generating reactive oxygen species (ROS) to kill cancer cells and induce immunogenic cell death (ICD).
• The effectiveness of PDT is significantly limited by the hypoxic tumor microenvironment, which reduces ROS production and impairs antitumor immunity.

Purpose of the Study:

• To develop a self-oxycarrying nanoassembly (POFF) that overcomes tumor hypoxia to enhance PDT efficacy.
• To investigate the potential of POFF for amplified photoimmunotherapy through improved ROS generation and hypoxia reversal.

Main Methods:

• Fabrication of a nanoassembly (POFF) integrating a Type-I near-infrared (NIR) photosensitizer (tetrafluorophenyl bacteriochlorin, FBC) with an oxygen-carrying perfluorocarbon moiety.
• Evaluation of POFF's self-oxycarrying capability, Type-I and Type-II photodynamic performance, and hypoxia alleviation effects in vitro and in vivo.
• Assessment of POFF's antitumor activity and immunogenic effects upon laser irradiation.

Main Results:

• The POFF nanoassembly demonstrated effective self-oxycarrying capability and enhanced both Type-I and Type-II photodynamic activities, successfully alleviating tumor hypoxia.
• In vitro and in vivo studies confirmed that POFF exhibited significant antitumor activity when irradiated with 750 nm laser light.
• PDT-induced cancer cell death via POFF led to the release of tumor-associated antigens, stimulating a robust antitumor immune response.

Conclusions:

• The developed POFF nanoassembly effectively ameliorates the hypoxic tumor microenvironment, a major challenge in PDT.
• POFF represents a promising strategy for amplifying the efficacy of photodynamic immunotherapy by enhancing ROS generation and triggering antitumor immunity.